ZYVERSA THERAPEUTICS, INC. Current Liabilities
ZYVERSA THERAPEUTICS, INC. (ZVSA) had Current Liabilities of $14.87 million as of 2026-03-31, per its 10-Q filed 2026-05-13.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2026-05-13
- 2026-03-31: Liabilities, Current $14.87M.
- 2025-12-31: Liabilities, Current $12.85M; Liabilities, Current as first filed $12.73M.
- 2025-09-30: Liabilities, Current $12.77M.
- 2025-06-30: Liabilities, Current $12.69M.
| Period end | Liabilities, Current | Liabilities, Current as first filed |
|---|---|---|
| 2026-03-31 | $14.87M 10-Q · filed 2026-05-13 | |
| 2025-12-31 | $12.85M 10-Q · filed 2026-05-13 | $12.73M 10-K · filed 2026-03-31 |
| 2025-09-30 | $12.77M 10-Q · filed 2025-11-19 | |
| 2025-06-30 | $12.69M 10-Q · filed 2025-08-13 | |
| 2025-03-31 | $12.00M 10-Q · filed 2025-05-12 | |
| 2024-12-31 | $11.23M 10-K · filed 2026-03-31 | |
| 2024-09-30 | $11.54M 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $9.99M 10-Q · filed 2024-08-09 | |
| 2024-03-31 | $9.58M 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $10.19M 10-K · filed 2025-03-27 | |
| 2023-09-30 | $11.71M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $10.48M 10-Q · filed 2023-08-21 | |
| 2023-03-31 | $8.58M 10-Q · filed 2023-05-12 | |
| 2022-12-31 | $8.19M 10-K · filed 2024-03-25 | |
| 2022-09-30 | $1.63M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $775.46K 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $828.46K 10-Q · filed 2022-05-13 | |
| 2021-12-31 | $276.83K 10-Q · filed 2022-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |